Posts by Sandra Ansanay-Alex
Alcon gets the International Influence Award at the Geneva Business Awards Ceremony
The winners of the 2025 Geneva Business Awards are: Taurus for the Innovation Award, Swissoja for the Industry Award, Alcon for the International Influence Award, Fondation Partage for the Special Jury Award, and Komgo SA for the Economy Award. Global eye care specialist Alcon inaugurated its global headquarters close to the Geneva airport in…
Read MoreHealthCare Konnect and Bonescreen Announce Strategic Partnership
Healthcare Konnect (HCK) and bonescreen partner to enhance early and accurate diagnosis of bone health disorders. Osteoporosis and related bone conditions affect millions worldwide, significantly impacting patient quality of life. Early detection is essential, yet conventional diagnostic methods often involve invasive procedures or expose patients to additional radiation, potentially limiting timely intervention and optimal…
Read MoreProf. Bloch and Prof. Courtine New Breakthrough for SCI Patients
In a rare double publication in Nature and Nature Medicine, landmark studies led by Professor Grégoire Courtine (EPFL), Professor Jocelyne Bloch (CHUV and University of Lausanne), and Dr. Aaron Phillips (University of Calgary) describe the development of a targeted therapy to stabilize blood pressure in SCI patients. Working with EPFL spin-off ONWARD Medical, the team…
Read MoreMecaplast Acquired by Irish Company Schivo
Mecaplast SA, is a highly specialised Swiss manufacturer of high-precision injection-moulded plastics, metals and ceramics for the medical device and life sciences sectors based in Botterens, in Canton of Fribourg. Founded in 1971, Mecaplast has earned a strong reputation for technical excellence and quality in producing mission-critical components, precision molds, and cleanroom assemblies for…
Read MoreLemna Bio Received CHF 150,000 from Venture Kick to Redefine Drug Discovery
EPFL spin-off Lemna Bio has raised CHF 150,000 from Venture Kick to develop its physics-driven AI platform, which makes biomolecular interactions more predictable, explainable, and reliable. The technology helps pharmaceutical companies identify better disease targets and design more effective therapies. Drug discovery today faces decade-long timelines, soaring costs, and a 90% clinical failure rate…
Read MoreNestlé: Pablo Isla Takes Over Paul Bulcke’s Position as Chairman
The Board of Directors of Nestlé S.A. has announced that Pablo Isla will become Chairman effective 1 October 2025, following Paul Bulcke’s decision to step down from the Board earlier than planned. Paul Bulcke, Chairman of Nestlé, stated: “I have full trust in Nestlé‘s new leadership and firmly believe this great company is well…
Read MoreHello Tomorrow Challenge
Apply before the 30 November 2025 for the Hello Tomorrow Challenge This is your chance to join the world’s longest-running deep tech competition and become part of our Deep Tech Pioneers community — a global network of 4,500+ startups, investors, corporates, and accelerators. Why apply? If selected as a Deep Tech Pioneer (DTP) you’ll…
Read MorePerivision Secures CHF 2.4M to Re-Imagine Eye Testing with AI and VR
The Vaud-based startup revolutionizes eye testing with a VR headset and an AI powered diagnostic tool Every year, millions of people risk losing their eyesight due to glaucoma and other diseases that often go undetected for too long. Globally, vision loss is estimated to cost the economy more than USD 400B annually, a burden…
Read MoreORYL Photonics Closes its Series A Round
ORYL Photonics announces the successful closing of its Series A round. The amount was not disclosed. The round was backed by existing shareholders. Their investment commitment has been achieved in record time (two weeks!). This milestone marks a major step forward for the fast-growing Swiss biotool company, which is pioneering advanced solutions for measuring the…
Read MoreEva.J and Bioressant: Pioneering Swiss Neurocosmetics Through Scientific Innovation
In the sophisticated landscape of contemporary skincare, where scientific rigor meets holistic wellness, Swiss company Bioressant and its flagship brand Eva.J Swiss Organic Neurocosmetics stand as exemplars of innovation at the convergence of neuroscience, dermatology, and biotechnology. Founded by Eva Johnston in Lausanne, this pioneering enterprise has established itself as a trailblazer in the emerging…
Read More